Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
09025-cover-mersanacxd.jpg

June 18, 2012 Cover

Volume 90, Issue 25

Following the recent success of two conjugates, companies are focused on developing the next generation of the cancer technology

Cover image:

Credit:

Full Article
Volume 90 | Issue 25

All Issues

Drug Delivery

Rethinking Antibody-Drug Conjugates

Following the recent success of two conjugates, companies are focused on developing the next generation of the cancer technology

  • New Applications For Glass Emerge

    As current as smartphones, as eternal as ancient Chinese tea sets, glass enjoys a clear advantage in many applications

  • India Reaps Benefits Of Carbon Program

    Sale of carbon credits is windfall for companies, but heady days are coming to an end

  • Grappling With The Elements

    Documentary filmmakers explore the human side of the periodic table

ADVERTISEMENT
image name
Pharmaceuticals

Method Flags Side Effects

Computational method identifies side-effect targets completely unrelated to therapeutic targets

ADVERTISEMENT
ADVERTISEMENT